...
首页> 外文期刊>Pediatric transplantation. >When does vesicoureteral reflux in pediatric kidney transplant patients need treatment?
【24h】

When does vesicoureteral reflux in pediatric kidney transplant patients need treatment?

机译:在儿科肾移植患者中的vesicoureteral回流何时需要治疗?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Purpose The treatment of VUR in children with UTI has changed significantly, due to studies showing that antibiotic prophylaxis does not decrease renal scarring. As children with kidney transplants are at higher risk for UTI, we investigated if select patients with renal transplant VUR could be managed without surgery. Materials and Methods A total of 18 patients with VUR into their renal grafts were identified, and 319 patients underwent transplantation from 2006 to 2016. The cause for the detection of the VUR, treatment, and graft function was reviewed. Results Six boys and 12 girls were identified, 13 of whom had grade 3 or 4 VUR into the renal graft. Nine patients presented with hydronephrosis or abnormal renal biopsy: eight were successfully managed with antibiotic prophylaxis and bladder training, one developed UTI and underwent Dx/HA subureteric injection. Nine patients presented with recurrent febrile UTI, only one was successfully managed without surgery. Only 2 of 9 (22%) patients who underwent Dx/HA injection had resolution of their reflux. Of the remaining seven, five required open ureteral reimplantation (two for obstruction), one lost the graft due to rejection, and one had significant hydronephrosis. eGFR was similar between the hydronephrosis, UTI, and abnormal renal biopsy groups at all times. Conclusion Patients with transplant VUR and recurrent febrile UTI are more likely to require surgical therapy, but the complication and failure rate for Dx/HA injection is significant. Patients with transplant VUR without febrile UTI can be successfully managed with bladder training and temporary antibiotic prophylaxis.
机译:摘要目的,uti治疗uti的vur的治疗显着改变了,由于表明抗生素预防不会降低肾疤痕。由于肾脏移植的儿童具有较高的UTI风险,因此如果在没有手术的情况下可以管理患有肾移植VUR的患者。综述了物料和方法将共18例VUR患者进入其肾移植物,2006年至2016年患有319名患者进行移植。检测检测VUR,治疗和移植功能的原因。结果确定了六个男孩和12名女孩,其中13岁或4级VUR进入肾移植物。患有肾内鼻病或肾活检异常的患者:8次以抗生素预防和膀胱训练成功进行管理,一个发达的UTI和接受DX / HA次射击剂。九名患者呈现出反复发热UTI,只有一个在没有手术的情况下成功管理。只有9名(22%)患者的2例(22%)患者患有DX / HA注射的患者已经解决了它们的回流。其余七,五个所需的张开输尿管再抑制(两个用于梗阻),人们因排斥而失去了移植物,一个有一个显着的肾内肾外衰分。 EGFR始终在肾内肾病,UTI和异常的肾活组织检查之间相似。结论移植VUR和复发性发热uti的患者更有可能需要手术治疗,但DX / HA注射的并发症和失效率是显着的。没有发热UTI的移植VUR患者可以用膀胱训练和临时抗生素预防成功进行成功管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号